Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8+ T Lymphocytes in the Female Reproductive Tract
Immunization strategies generating large numbers of antigen-specific T cells in the female reproductive tract (FRT) can provide barrier protection against sexually-transmitted pathogens, such as the human immunodeficiency virus (HIV) and human papillomaviruses (HPV). The kinetics and mechanisms of r...
Main Authors: | Shailbala Singh, Kimberly S. Schluns, Guojun Yang, Scott M. Anthony, Michael A. Barry, K. Jagannadha Sastry |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/4/1/7 |
Similar Items
-
Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease
by: William Walkowski, et al.
Published: (2021-06-01) -
Clinical and pharmacokinetics overview of intranasal administration of fentanyl
by: Samaneh Nakhaee, et al.
Published: (2023-12-01) -
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens
by: David M. Koelle, et al.
Published: (2022-03-01) -
Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
by: Francesca Cossovel, et al.
Published: (2022-01-01) -
Comparative study between intranasal dexmedetomidine and intranasal ketamine as a premedication for anxiolysis and sedation before pediatric general anesthesia
by: Ahmed Elsayed Ahmed Mohamed Elshafeey, et al.
Published: (2020-10-01)